Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Clarcor Q1 Profit Rises; Confirms FY12 EPS View - Quick Facts

RELATED NEWS
Trade CLC now with 

Clarcor Inc. (CLC: Quote) reported that its first-quarter net earnings attributable to the company rose to $23.48 million or $0.46 per share, from $21.88 million or $0.43 per share in the same quarter last year. Analysts polled by Thomson Reuters expected the company to report earnings of $0.47 per share for the quarter. Analysts' estimates typically exclude special items.

Net sales for the quarter rose to $257.26 million from $245.72 million in the prior year quarter. Four analysts had consensus revenue estimate of $267.93 million for the quarter.

The company confirmed its 2012 earnings guidance in a range of $2.55 to $2.70 per share. Analysts expect the company to report earnings of $2.68 per share for fiscal 2012.

Click here to receive FREE breaking news email alerts for CLARCOR Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Oracle Corp. said Thursday after the markets closed that its first quarter profit fell slightly from last year, hurt mainly by higher income tax expenses even as revenue increased 3%. The company's quarterly earnings per share, excluding items, also came in below analysts' expectations as did its quarterly revenue. After ending the previous session mostly higher following the Federal Reserve's monetary policy announcement, stocks saw further upside during trading on Thursday. The gains on the day lifted the Dow and the S&P 500 to new record closing highs. Incumbent Colorado Sen. Mark Udall, D-Col., trails his Republican challenger in the latest Quinnipiac University poll, with more than a third of likely voters describing their U.S. Senate vote as a vote against President Barack Obama.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.